跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,394 条关于
“DKA”
全部
3,394
临床试验
2,593
药物
515
机构
48
资讯
238
6年前
Increased Risk of Diabetic Ketoacidosis with Sotagliflozin in Type 1 Diabetes Patients
去年
FDA Panel Rejects Sotagliflozin for Type 1 Diabetes with Mild-to-Moderate CKD
去年
FDA Panel Rejects Sotagliflozin for Type 1 Diabetes and CKD
去年
Sotagliflozin Faces Setback as FDA Advisory Committee Recommends Against Approval for T1D and Chronic Kidney Disease
去年
FDA Reviewers Express Concerns Over Sotagliflozin's Safety for Type 1 Diabetes Patients with CKD
去年
Sotagliflozin Shows Promise in Type 1 Diabetes with Chronic Kidney Disease
去年
FDA Rejects Lexicon's Zynquista for Type 1 Diabetes and Chronic Kidney Disease
去年
FDA Panel Rejects Zynquista for Type 1 Diabetes and Chronic Kidney Disease
去年
CHMP Backs Sanofi's Zynquista for Type 1 Diabetes in Overweight/Obese Patients
去年
Lexicon's Sotagliflozin Faces FDA Panel Again with Narrowed Indication for Type 1 Diabetes and Chronic Kidney Disease
第 1 页,共 24 页
上一页
下一页